BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dayangan Sayan C, Tulmac OB, Karaca G, Ozkan ZS, Yalcin S, Devrim T, Dindar Badem N. Could erythropoietin reduce the ovarian damage of cisplatin in female rats? Gynecological Endocrinology 2018;34:309-13. [DOI: 10.1080/09513590.2017.1395836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Sonigo C, Beau I, Binart N, Grynberg M. Medical Treatments for Ovarian Protection. Female and Male Fertility Preservation 2022. [DOI: 10.1007/978-3-030-47767-7_27] [Reference Citation Analysis]
2 Talebi A, Hayati Roodbari N, Reza Sameni H, Zarbakhsh S. Impact of coadministration of apigenin and bone marrow stromal cells on damaged ovaries due to chemotherapy in rat: An experimental study. Int J Reprod Biomed 2020;18:551-60. [PMID: 32803119 DOI: 10.18502/ijrm.v13i7.7372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yıldırım N, Karatas A, Cengiz M, Onalan E, Yazıcı GN, Sunar M, Mammadov R, Coban A, Suleyman H. Protective effect of adenosine triphosphate against sunitinib-related skin damage in rats. Hum Exp Toxicol 2020;39:1737-46. [PMID: 32677474 DOI: 10.1177/0960327120940365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Xie Y, Li S, Zhou L, Lin H, Jiao X, Qiu Q, Liang Y, Zhang Q. Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo. Mol Reprod Dev 2020;87:442-53. [PMID: 32112509 DOI: 10.1002/mrd.23330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Anğın AD, Gün I, Sakin Ö, Çıkman MS, Şimşek EE, Karakuş R, Başak K, Kaptanağası AO. Investigation of the preventive effects of dehydroepiandrosterone (DHEA) and Caffeic acid phenethyl ester (CAPE) on cisplatin-induced ovarian damage in rats. Ultrastruct Pathol 2020;44:71-80. [PMID: 31909696 DOI: 10.1080/01913123.2019.1711479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sonigo C, Beau I, Binart N, Grynberg M. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage. Int J Mol Sci 2019;20:E5342. [PMID: 31717833 DOI: 10.3390/ijms20215342] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
7 Kim SY, Cho GJ, Davis JS. Consequences of chemotherapeutic agents on primordial follicles and future clinical applications. Obstet Gynecol Sci 2019;62:382-90. [PMID: 31777733 DOI: 10.5468/ogs.2019.62.6.382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
8 Chen H, Xiao L, Li J, Cui L, Huang W. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2019;3:CD008018. [PMID: 30827035 DOI: 10.1002/14651858.CD008018.pub3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]